Pfizer: 40 years of TBE production in Austria

The active ingredients of some 10 million doses of the TBE vaccine are currentlyproduced in Austria annually. The vaccine protects against all known TBE-virus subtypes and has been developed by virologists at the University of Vienna 40 years ago.

Sorry, this entry is only available in German!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)